欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/2209/003
药品名称Gabapentin Adalvo
活性成分
    • gabapentin 600.0 mg
    • gabapentin 300.0 mg
剂型Prolonged-release tablet
上市许可持有人Adalvo Limited Sir Temi Zammit Buildings 4 Malta Life Sciences Park Building 1 Level San Gwann 3000 Malta
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • France (FR)
    • Germany (DE)
      Gabapentin Adalvo 300 mg + 600 mg Titrationspackung mit Retardtabletten
    • Spain (ES)
    • Italy (IT)
许可日期2022/12/15
最近更新日期2022/12/16
药物ATC编码
    • N03AX12 gabapentin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase